From the Desk of Richard Drachtman
With the integration of the Cancer Institute of New Jersey into Rutgers, the faculty will have unprecedented access to basic scientists allowing for increased collaboration with the goal of providing translational research that flows seamlessly from the clinic to the laboratory, allowing for the incorporation of new discoveries to better serve our pediatric hematology-oncology patients.
Richard Drachtman MD
Interim Director, Pediatric Hematology Oncology
Rutgers Cancer Institute of New Jersey
Professor of Pediatrics
Robert Wood Johnson Medical School